Nov 06, 2019 · Their average twelve-month price target is $8.93, suggesting that the stock has a possible upside of 371.16%. The high price target for BCRX is $15.00 and the low price target for BCRX is $4.00. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."

BCRX stock rating and analysis - BioCryst Pharmaceuticals : a summary of key financial strength and profitability metrics. BCRX Insider Trading Activity (BioCryst Pharmaceuticals) Which company executives are buying and selling shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) stock? View the most recent insider trading activity for BCRX stock at MarketBeat. BCRX Stock Quote of Biocryst Pharma Inc - InvestorPlace Check out our BCRX stock analysis, current BCRX quote, charts, and historical prices for Biocryst Pharma Inc stock BCRX | BioCryst Pharmaceuticals Inc. Stock Price & News - WSJ BioCryst Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time BCRX stock price.

BioCryst Pharmaceuticals Inc. Message board - Online Community of active, educated investors researching and discussing BioCryst Pharmaceuticals Inc. Stocks.

Real time BioCryst Pharmaceuticals (BCRX) stock price quote, stock graph, news & analysis. Real time BioCryst Pharmaceuticals (BCRX) stock price quote, stock graph, news & analysis. Biocryst Pharmaceuticals, Inc. - BCRX - Stock Price Today ... View BioCryst Pharmaceuticals, Inc. BCRX investment & stock information. Get the latest BioCryst Pharmaceuticals, Inc. BCRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. BCRX | BioCryst Pharmaceuticals Inc | Dividend History ... BCRX Dividend History & Description — BioCryst Pharmaceuticals Inc. BioCryst Pharmaceuticals is a biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. BCRX | BioCryst Pharmaceuticals Inc | Dividend History ...

1 day ago BioCryst Pharmaceuticals (BCRX) stock changed position at 5.13% to closing price of $2.05 in last trading session. The last closing price 

BCRX: Get the latest BioCryst Pharmaceuticals stock price and detailed information including BCRX news, historical charts and realtime prices. Stock Price Forecast for BCRX: BioCryst Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. View BioCryst Pharmaceuticals, Inc.'s fair value, stock price, financial statements, news, valuation models, fundamental charts, $2.57. Price History Edited Transcript of BCRX earnings conference call or presentation 5-Mar-20 1:30pm GMT. Stock Price Forecast. The 8 analysts offering 12-month price forecasts for BioCryst Pharmaceuticals Inc have a median target of 6.50, with a high estimate of  BioCryst Pharmaceuticals, Inc Stock Chart and Share Price Forecast, Short-Term "BCRX" Stock Prediction  Get breaking news and analysis on BioCryst Pharmaceuticals, Inc. (BCRX) stock, price quote and chart, trading and investing tools.

BioCryst Pharmaceuticals Historical Data - BCRX | ADVFN

BCRX's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low BioCryst Pharmaceuticals, Inc. (BCRX) Dividend Date &amp ... See the upcoming ex dividend date and dividend history for BioCryst Pharmaceuticals, Inc. (BCRX). Stay alerted to dividend announcements for BCRX and all the companies you follow at NASDAQ.com

BioCryst Pharmaceuticals, Inc. BCRX 1.93 0.12 (5.88%). NASDAQUpdated Apr 7 , 2020 11:52 PM. 8,841. Watchers. Watch. Filter by: Real-Time 

Discover historical prices for BCRX stock on Yahoo Finance. View daily, weekly or monthly format back to when BioCryst Pharmaceuticals, Inc. stock was issued. Historical daily share price chart and data for BioCryst Pharmaceuticals since 1994 adjusted for splits. The latest closing stock price for BioCryst Pharmaceuticals  Records 1 - 18 of 21 Find the latest historical data for BioCryst Pharmaceuticals, Inc. Common Stock ( BCRX) at Nasdaq.com. View live BIOCRYST PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, BCRX financials and market news.

BCRX - Biocryst Pharma Stock Performance Report - Barchart.com Historical performance for Biocryst Pharma Inc (BCRX) with historical highs & lows, new high & low prices, past performance, latest news. BCRX - BioCryst Pharmaceuticals, Inc. Summary, Stock Quote ... BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance BCRX BioCryst Pharmaceuticals, Inc. Stock Quote BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor, for the treatment of acute uncomplicated influenza under the RAPIVAB, ALPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma. Biocryst Pharmaceuticals Inc. BCRX - Quotes, Financials ...